Research Library

From 2020 to 2023, sales of hemp-derived cannabinoids increased by 1,283%, reaching a value of $2.78 billion last year. Although the Texas hemp industry is booming, lack of regulation poses risks to public health. A new brief from the Drug Policy Program makes specific recommendations for strengthening and enforcing current laws — ensuring consumer safety while also providing economic benefits for the state.

On October 12, 2022, Katharine Neill Harris, the Alfred C. Glassell, III, Fellow in Drug Policy, testified before the Texas House of Representatives Interim Study Committee on Criminal Justice Reform. Her written testimony addresses the committee's inquiry into policies and penalties relating to drug offenses.

According to the authors, as a leading agricultural state, Texas is poised to become the new leader in hemp production, whether for medicinal or industrial purposes.

Products containing hemp extracts high in CBD are gaining mainstream popularity, acceptance and federal legality. In this article, Lisa Pittman, nonresident fellow in drug policy, focuses on litigation issues particular to hemp.

Marijuana decriminalization and legalization have gone past being a trend and are settling in as federal policy, writes nonresident fellow Gary Hale, a 31-year veteran of the Drug Enforcement Administration. This policy brief includes recommendations for how the DEA can adjust its policies to adopt a new paradigm on marijuana policy.

By Jerry Epstein

Following the legalization of retail marijuana sales in Colorado and Washington, and medical marijuana…

In 2012, the Drug Policy Program at Rice University’s Baker Institute and the South Texas College of Law (STCL) established a unique agreement to work together on model legislation for the decriminalization and regulation of marijuana in Texas. The collaboration was initiated by students and supported by the administrations and faculties of both educational institutions. South Texas College of Law students produced 19 separate statutes for their public law course in the spring 2013 semester. They were asked to write model legislation regarding some aspect of marijuana policy and provide well-reasoned commentary for their statutes. Experts from the Baker Institute’s Drug Policy Program gave guest lectures on drug policy issues and worked with STCL professor Drury Stevenson to provide a general direction for the course. The goal of the collaboration between the STCL and the Baker Institute was to create a variety of statutes that legislators and government officials can consult and learn from as marijuana policy is increasingly debated over the next decade. Neither the Baker Institute nor the South Texas College of Law endorses any particular policy. The model legislation has not undergone editorial review by the Baker Institute.